0.8673
2.19%
-0.0194
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
14.94%
32.33
|
28.12 | 35.32 | 32.17 | 30.42 |
Operating Income/Loss |
14.94%
-32.33
|
-28.12 | -35.32 | -32.17 | -30.42 |
Nonoperating Income/Loss |
18.30%
1.522
|
1.863 | 2.126 | 2.195 | 1.989 |
Income/Loss From Continuing Operations Before Tax |
17.30%
-30.80
|
-26.26 | -33.19 | -29.98 | -28.43 |
Income/Loss From Continuing Operations After Tax |
17.30%
-30.80
|
-26.26 | -33.19 | -29.98 | -28.43 |
Net Income/Loss
|
17.30%
-30.80
|
-26.26 | -33.19 | -29.98 | -28.43 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
31,078%
68.03
|
0.2182 | 67.61 | 67.03 | 66.27 |
Diluted Average Shares |
31,078%
68.03
|
0.2182 | 67.61 | 67.03 | 66.27 |
Basic Earnings Per Share |
18.42%
-0.45
|
-0.38 | -0.49 | -0.45 | -0.43 |
Diluted Earnings Per Share |
18.42%
-0.45
|
-0.38 | -0.49 | -0.45 | -0.43 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):